Skip to main content

Table 3 Duration of omalizumab therapy with total IgE and sIgE before and after treatment

From: Omalizumab in children with severe allergic disease: a case series

Patient Duration of treatment
(weeks)
Total Serum IgE (IU/L) Serum IgEs (KU/L)
Before treatment After treatment Before treatment After treatment
1 78 1003 490 DP = 100
DF = 82
Olive = 68
Milk = 2.14
DP = 59.3
DF = 36.3
Olive = 1.41
2 96 372 760 DP = 100
DF = 100
Pellitory = 12
DP = 100
DF = 100
Pellitory = 3.85
3 16 668 309 Milk > 100
Bos d 8 = 100
Bos d 4 = 15.8
Bos d 5 = 9.26
Milk > 100
Bos d 8 > 100
Bos d 4 = 20.3
Bos d 5 = 8.4
4 104 280 126 DP = 62.8
DF = 31.3
DP = 70
DF = 30.9
5 16 68.8 35 Milk = 20.9
Bos d 8 = 18.1
Bos d 4 = 5.73
Bos d 5 = 3.49
Milk = 8.93
Bos d 8 = 5.18
Bos d 4 = 4.09
Bos d 5 = 1.6
6 48 597 930 DP = 1.18
DF = 1.12
Milk = 90
Bos d 8 = 62.3
Bos d 4 = 62.5
Bos d 5 = 36.6
Der. P 0.25
Der. F 0.13
Milk > 100
Bos d 8 = 100
Bos d 4 > 100
Bos d 5 = 69.3
7 16 79.9 71 Milk = 25.1
Bos d 8 = 16
Bos d 4 = 5.99
Bos d 5 = 4.24
Milk = 9
Bos d 8 = 4.06
Bos d 4 = 2.93
Bos d 5 = 1.61
8 48 972 309 DP = 17.1
DF = 23.4
Pellitory = 20.7
Cat = 9.51
Milk > 100
Bos d 8 > 100
Bos d 4 = 15.8
Bos d 5 = 9.26
DP = 2.54
DF = 25.9
Pellitory = 18.1
Cat = 4.9
Milk > 100
Bos d 8 > 100
Bos d 4 = 3.87
Bos d 5 = 2.4
  1. Abbreviation: IgE immunoglobulin E